Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 1
2004 2
2005 1
2006 1
2007 1
2008 4
2009 4
2010 9
2011 3
2012 6
2013 8
2014 3
2015 7
2016 3
2017 4
2018 9
2019 8
2020 11
2021 19
2022 15
2023 13
2024 5

Text availability

Article attribute

Article type

Publication date

Search Results

116 results

Results by year

Filters applied: . Clear all
Page 1
Monitoring mepolizumab treatment in chronic rhinosinusitis with nasal polyps (CRSwNP): Discontinue, change, continue therapy?
Klimek L, Förster-Ruhrmann U, Olze H, Beule AG, Chaker AM, Hagemann J, Huppertz T, Hoffmann TK, Dazert S, Deitmer T, Strieth S, Wrede H, Schlenter WW, Welkoborsky HJ, Wollenberg B, Becker S, Bärhold F, Klimek F, Casper I, Zuberbier J, Rudack C, Cuevas M, Hintschich CA, Guntinas-Lichius O, Stöver T, Bergmann C, Werminghaus P, Pfaar O, Gosepath J, Gröger M, Beutner C, Laudien M, Weber RK, Hildebrand T, Hoffmann AS, Bachert C. Klimek L, et al. Among authors: strieth s. Allergol Select. 2024 Mar 21;8:26-39. doi: 10.5414/ALX02460E. eCollection 2024. Allergol Select. 2024. PMID: 38549814 Free PMC article. Review.
Hypermethylated SHOX2 in circulating cell-free DNA post renal cell carcinoma surgery as TNM-independent biomarker for recurrence risk.
Büttner T, Zarbl R, Krausewitz P, Strieth S, Kristiansen G, Eckstein M, Ralser DJ, Hölzel M, Ritter M, Ellinger J, Dietrich D, Klümper N. Büttner T, et al. Among authors: strieth s. Am J Transl Res. 2024 Jan 15;16(1):304-313. doi: 10.62347/QOBT7285. eCollection 2024. Am J Transl Res. 2024. PMID: 38322559 Free PMC article.
PD-L1 (CD274) promoter hypomethylation predicts immunotherapy response in metastatic urothelial carcinoma.
Klümper N, Wüst L, Saal J, Ralser DJ, Zarbl R, Jarczyk J, Breyer J, Sikic D, Wullich B, Bolenz C, Roghmann F, Hölzel M, Ritter M, Strieth S, Hartmann A, Erben P, Wirtz RM, Landsberg J, Dietrich D, Eckstein M. Klümper N, et al. Among authors: strieth s. Oncoimmunology. 2023 Oct 19;12(1):2267744. doi: 10.1080/2162402X.2023.2267744. eCollection 2023. Oncoimmunology. 2023. PMID: 37868689 Free PMC article.
[Clinical Management of Choanal Atresia].
Maas AP, Strieth S, Send T. Maas AP, et al. Among authors: strieth s. Laryngorhinootologie. 2024 Jan;103(1):25-34. doi: 10.1055/a-2160-2777. Epub 2023 Sep 19. Laryngorhinootologie. 2024. PMID: 37726020 German.
Circulating Cell-Free SEPT9 DNA Methylation in Blood Is a Biomarker for Minimal Residual Disease Detection in Head and Neck Squamous Cell Carcinoma Patients.
Dietrich D, Weider S, de Vos L, Vogt TJ, Färber M, Zarbl R, Hunecke A, Glosch AK, Gabrielpillai J, Bootz F, Bauernfeind FG, Kramer FJ, Kristiansen G, Brossart P, Strieth S, Franzen A. Dietrich D, et al. Among authors: strieth s. Clin Chem. 2023 Sep 1;69(9):1050-1061. doi: 10.1093/clinchem/hvad084. Clin Chem. 2023. PMID: 37477541
CTLA4 DNA methylation is associated with CTLA-4 expression and predicts response to immunotherapy in head and neck squamous cell carcinoma.
Hoffmann F, Franzen A, de Vos L, Wuest L, Kulcsár Z, Fietz S, Maas AP, Hollick S, Diop MY, Gabrielpillai J, Vogt T, Kuster P, Zarbl R, Dietrich J, Kristiansen G, Brossart P, Landsberg J, Strieth S, Dietrich D. Hoffmann F, et al. Among authors: strieth s. Clin Epigenetics. 2023 Jul 6;15(1):112. doi: 10.1186/s13148-023-01525-6. Clin Epigenetics. 2023. PMID: 37415208 Free PMC article.
116 results